Raymond James Financial
VERA icon

Raymond James Financial’s Vera Therapeutics VERA Stock Holding History

Raymond James Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Buy
78,337
+13,138
+20% +$490K ﹤0.01% 3072
2026
Q1 		$2.62M Buy
65,199
+324
+0.5% +$14K ﹤0.01% 3139
2025
Q4 		$3.29M Buy
64,875
+6,370
+11% +$226K ﹤0.01% 2853
2025
Q3 		$1.7M Sell
58,505
-47,662
-45% -$1.1M ﹤0.01% 3294
2025
Q2 		$2.5M Sell
106,167
-9,865
-9% -$222K ﹤0.01% 2897
2025
Q1 		$2.79M Buy
116,032
+46,308
+66% +$1.49M ﹤0.01% 2754
2024
Q4 		$2.95M Buy
+69,724
New +$3.09M ﹤0.01% 2687

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Raymond James Financial's VERA Position: Q2 2026 in Review

Raymond James Financial increased its Vera Therapeutics (VERA) stake by 20% in Q2 2026, buying an estimated $490K and bringing the position to 78,337 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Raymond James Financial first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Raymond James Financial held 78,337 shares of Vera Therapeutics worth $3.36M as of Q2 2026.
  • Raymond James Financial bought 13,138 Vera Therapeutics shares in Q2 2026, an estimated $490K.
  • Vera Therapeutics made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3072 holding.
  • Raymond James Financial first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.